1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Pellegrini, M.
Liehr, S.
Fisher, A.L.
Cooperman, B.S.
Mierke, D.F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
12210
12215
10.1021/bi001323a
11015199
Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase.
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
940.028
SYNTHETIC CYCLIC PEPTIDE
1
syn
polymer
no
yes
(ACE)FELDKDF
XFELDKDF
A
polypeptide(L)
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
1
0
2000-11-22
1
1
2008-04-27
1
2
2011-07-13
RCSB
Y
RCSB
2000-08-29
REL
The peptide was synthesized by solid phase synthesis.
sample
back calculated data agree with experimental NOESY spectrum
100
3
ACE
1
n
1
ACE
1
A
PHE
2
n
2
PHE
2
A
GLU
3
n
3
GLU
3
A
LEU
4
n
4
LEU
4
A
ASP
5
n
5
ASP
5
A
LYS
6
n
6
LYS
6
A
ASP
7
n
7
ASP
7
A
PHE
8
n
8
PHE
8
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
GLU
3
71.91
54.38
1
A
ASP
5
158.67
76.52
2
A
GLU
3
72.31
53.44
2
A
ASP
5
160.37
75.62
3
A
ASP
5
159.10
79.50
CYCLIC PEPTIDE INHIBITOR
STRUCTURE OF CYCLIC PEPTIDE INHIBITORS OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE
1
N
N
covale
1.343
A
GLU
3
A
CD
GLU
3
1_555
A
LYS
6
A
NZ
LYS
6
1_555
covale
1.335
A
ACE
1
A
C
ACE
1
1_555
A
PHE
2
A
N
PHE
2
1_555
OXIDOREDUCTASE INHIBITOR
transferred NOEs, IRMA refinement, ribonucleotide reductase inhibitors, OXIDOREDUCTASE INHIBITOR
1FOZ
PDB
1
1FOZ
1
8
1FOZ
1
8
1FOZ
A
1
1
8
1
P 1